This paper presents a contribution to the definition of the interfaces required to perform heterogeneous model integration in the context of integrative physiology. A formalization of the model integration problem is proposed and a coupling method is presented. The extension of the classic Guyton model, a multi-organ, integrated systems model of blood pressure regulation, is used as an example of the application of the proposed method. To this end, the Guyton model has been restructured, extensive sensitivity analyses have been performed, and appropriate transformations have been applied to replace a subset of its constituting modules by integrating a pulsatile heart and an updated representation of the renineangiotensin system. Simulation results of the extended integrated model are presented and the impacts of their integration within the original model are evaluated.
Introduction
The central role of modeling and simulation in the analysis of biological and physiological systems is now established, and numerous mathematical models of physiological systems can be found in the literature. This is particularly important in the domain of cardiovascular and renal (CVR) pathophysiology. A number of models focusing on structural (or vertical) integration have been proposed, for example, for the multi-scale analysis of the electrical activity of the heart (Clayton et al., 2011; Clayton and Panfilov, 2008) , or for cardiac electromechanics (Kerckhoffs et al., 2006; Nordsletten et al., 2011) . These structurally-integrated models have proven useful for understanding various pathological conditions. However, they are often complex in terms of the number of state variables or structural elements represented, and they may lack an appropriate physiological description of boundary conditions. Such models are typically computationally intensive and difficult to analyze, to identify, and thus to exploit in a practical context. Models aiming at functional (or horizontal) integration, representing the interaction between different organs or physiological subsystems, are particularly suited for the analysis of multifactorial pathologies. These models are easier to manage numerically and mathematically, since they are usually based on a lumpedparameter representation. However, their clinical applicability may be limited by the fact that their constitutive elements generally lack the level of detail required to address certain pathophysiological functions.
The work presented here is focused on the analysis of the dynamic and integrated behavior of the cardiovascular and renal systems (CVR), which are involved in major public health pathologies, such as heart failure and hypertension. These CVR pathologies are complex and multifactorial, strongly drawing their clinical features and consequences from intertwined and dynamic interactions between genotype, phenotype, and environment (McMurray, 2010) . This very complexity (number of elements, multiscale interactions, adaptations, nonlinearity.) makes a complete horizontal and vertical integration impossible.
One way to overcome these limitations is to represent the various physiological components of interest by separate specific models, developed at distinct levels of structural complexity, as a function of the targeted clinical application. However, such different models are often developed under a variety of mathematical formalisms, use distinct structural resolutions, or present significant differences in their intrinsic dynamics. Coupling these heterogeneous models into a multi-resolution approach presents a number of methodological and technical difficulties, particularly:
1. the creation of an appropriate environment based on a modular, horizontally integrated 'core model' and on specific tools for modeling and simulating a set of coupled heterogeneous models; and 2. the definition of an interfacing method for coupling these formally heterogeneous models, while preserving the stability and the essential characteristics of each integrated model.
Concerning the first point, the classic Guyton model (Guyton et al., 1972) , a multi-organ, integrated systems model of blood pressure regulation, was implemented within the SAPHIR project (funded by the French ANR BioSYS program and selected as an Exemplar Project of the VPH NoE 1 ), as an example of system-level horizontal integration that can be useful for the definition of an extensible core model (Thomas et al., 2008) . This implementation was based on an objectoriented multi-resolution modeling tool (M2SL) that allowed us to create the corresponding modules of the Guyton model as individual physiological and functional components. These components were coupled through specific input/output interfaces, without the need to explicitly specify integration step-sizes for each module, despite the wide range of time-scales covered ).
This paper focuses on the second point. We present a modeling approach in which a system-level 'core model', devoted to functional integration, is selectively improved by interfacing more detailed models of specific functions, defined at different levels of structural integration. This is demonstrated with concrete application examples. Section 2 formalizes the problem and presents a general method for coupling heterogeneous models. Section 3 presents results from an extensive sensitivity analysis of the original Guyton model, as well as two examples of the application of the proposed method for the replacement of some modules of the Guyton model by updated models: a pulsatile model of cardiac activity and an updated representation of the renineangiotensin system. Finally, section 4 places the present work within the context of integrative physiology and outlines some perspectives.
Methods

Core model
Two different versions of the classic Guyton models were reimplemented during the SAPHIR project: the initial version, published in 1972 (M G72 ) (Guyton et al., 1972) and a more complete version that has been used in other work by people from Guyton's group (M G92 ) (Montani and Van Vliet, 2009) . 2 No complete formal description of either version has been published, though all the principles and explanations for most of the parameter choices can be found in the three books by Guyton and colleagues (Guyton, 1973 (Guyton, , 1975 (Guyton, , 1980 
where F is the mathematical formalism in which each model is represented, I, O, E and P are vectors containing, respectively, the input, output, state variables and the parameters of each model, and fM G;i g is the set of original N atomic or coupled sub-models constituting M Coup . Both the M G72 and M G92 models are coupled models composed of N ¼ 25 atomic sub-models. These atomic submodels are represented with continuous formalisms being based either on differential or algebraic equations, as in their original description by Guyton et al. Although it was published over 30 years ago, the Guyton model remains a landmark achievement, and with the rise in the last 10 years of systems physiology, it has attracted renewed attention (Karaaslan et al., 2005; Kofranek et al., 2007; Malpas, 2009; Mangourova, 2011) . This model was the first 'whole-body', integrated mathematical model of a physiological system. It allows for the dynamic simulation of systemic circulation, arterial pressure, and body fluid regulation, including short-and long-term regulations. Fig. 1 depicts the modular structure of the Guyton model and shows the main compartments and volume flows represented in the model.
Guyton's original model is constructed around a 'central' circulatory dynamics module in interaction with 'peripheral' modules corresponding to physiological functions. In previous work, we re-implemented the Guyton models (M G72 and M G92 ) in FORTRAN, Cþþ (M2SL), and Simulink and evaluated the performance of these functioning re-implementations. For example, in (Thomas et al., 2008) , we simulated for M G72 the in silico experiments described in the original Guyton paper (Guyton et al., 1972) , and we verified that our results correctly match the outputs from the original FORTRAN program in Guyton's laboratory.
However, one of the main limitations of the Guyton models is the low-resolution description of most of its constituting modules. The objective of the present work is thus to present a framework to replace some of the original sub-modules of the Guyton models by new models presenting a higher temporal or spatial resolution. The modular implementation under M2SL was a key step preliminary to the replacement of the original modules by updated or more detailed versions.
Sub-model interfacing method
In order to formalize the sub-model interfacing method, we may define several model sets (see Fig. 2 ). As proposed in the previous section, M G represents the set of N original atomic or coupled submodels constituting the 'core-model' (M G72 or M G92 in our case). This set, represented in Fig. 2 as an ellipse, can be partitioned into two subsets: fM R;j g4fM G;i g, j ¼ 1,.,N R including the sub-models that we wish to replace (white part of the ellipse in Fig. 2) , and fM C;l g ¼ fM G;i g À fM R;j g, l ¼ 1,.,Nc; Nc ¼ NeN R containing the sub-models that will be conserved from the original model (gray part of the ellipse). Furthermore, let fM D;k g (truncated ellipse with segmented lines in Fig. 2 ) be the set of k ¼ 1,.,N D new, more detailed models that we wish to integrate instead of M R . We may also define the following vectors: I U;v , O U;v , E U;v and P U;v (see equation (1)) containing input, output, state variables, and parameters of each model v in M U , where U˛fG; R; D; Cg for the original (Guyton), replaced, detailed and conserved model sets, respectively. These vectors will be useful for the definition of the interface between models in different sets. The proposed approach for replacing M R by M D and for interfacing M D with M C is the following:
1. Identification of the variables involved in the interaction of models in M C , M R and M D . Six sets can be defined in this step, from the analysis of vectors I U;v and O U;v . These sets contain the inputs and outputs of a given model set, which depend on outputs and inputs of models pertaining to a different set (rounded boxes with double lines in Fig. 2 ). 
where n and m are the indexes of each input or output vector, respectively. During the model replacement procedure, the links between O R and I C and between O C and I R (dotted arrows in Fig. 2), will be removed. M2SL provides tools to automate this first step. Guyton et al., 1972) , overlaid with names of the various submodules; (B) the distribution of blood as it flows through the main compartments of the general circulation, namely right atrium (VRA), left atrium (VLA), systemic arteries (VAS) and veins (VVS), and pulmonary arteries (VPA). The variables QVO, QRO, QPO, and QLO represent blood flow at various points along the circulation. BFM and BFN are the muscle and non-muscle blood flow, respectively, and RBF is the renal blood flow. The terms PLA, PPA, PRA, PA and PVS represent the five compartmental pressures, relative to atmospheric pressure. Baseline values for certain variables are shown. (with permission from Thomas et al., 2008) . ). The original model set (M G ) is represented with an ellipse and is the union of two subsets: a subset containing models that will be conserved (M C , in gray) and a subset of models that will be replaced (M R ). The set M D (segmented lines) includes detailed models that will be used to replace models in M R . Rounded boxes with double lines represent the sets of inputs or outputs of a given model set that are connected to models into another set. Transformations T D,C and T C,D perform the input/output interface between models in M C and M D . It should be noted that the method presented above may be applied to any coupled model, even if it is a sub-module of a higherlevel coupled model or if models in M D and M R contain coupled models.
Whole-model and module-based sensitivity analyses
As stated above, we carried out two kinds of sensitivity analyses: i) a whole-model analysis of the response of the main variables to changes in the model parameter values, and ii) a module-based sensitivity analysis of all the O R,j to changes in I R,j for each submodel in M R . For both cases, a complete sensitivity analysis would involve testing the effects of successive changes in several model parameters or input variables, since physiological adjustments are of this sort, but this would be a daunting undertaking given the number of possible combinations. In the present study, the sensitivity analysis is focused on the effects of perturbations of one parameter or input variable at a time, based on the screening method of Morris (Morris, 1991) . This method was chosen because it provides not only a measure of the effect of each parameter on each variable, but also gives information on nonlinearities and interactions among variables and parameters, by means of the analysis of the mean (m) and standard deviation (s) of a set of normalized measures of parameter (or input) sensitivity, defined as "elementary effects". In this analysis, m indicates the relative sensitivity of a given output to a specific parameter (in the global model) or input variable (for isolated modules), and s gives a measure of the dependence of the sensitivity on the values of the other inputs. Module-based sensitivity analysis was performed by directly applying the Morris method, as described in his paper. More details on the Morris screening method are presented in Appendix A.
Briefly, concerning the whole-model sensitivity analysis, a Monte Carlo approach was applied by repeating the Morris method a large number of times (i.e., 1000 here) for a number of selected parameters; since many of the more than 200 model parameters have no physiological significance (i.e., many are for internal looping control or represent technical implementation details), we selected 96 parameters for their putative physiological relevance in the model. Thus, this process produced 192,000 'virtual individuals' with randomized parameter values. For each instance, the values of all selected parameters were chosen at random within a viable range, and the simulation was run to steady state (4 weeks of simulated time) before effecting a parameter perturbation (10% of the valid range for each given parameter, see below). This provides i) a large, steady state virtual population that can be explored statistically for relationships among the model parameters and variables, and ii) a one-at-a-time parameter sensitivity analysis giving the mean (m) and standard deviation (s) for the normalized effect of each of the selected model parameters on each of the model output variables. Given the nonlinearity and the strong interdependence of the system, we tracked the sensitivity effects over time, focusing both on mid-term changes (5 min, 1 h) and longer-term effects (1 day and 1 week). This raises the question of following up with optimization studies in search of, for example, unsuspected scenarios leading to hypertension, but these lie outside the present work. We also carried out a covariance analysis (results not given here) that gives valuable information about the interdependencies of parameter effects on any given variable, thus providing pointers for a more physiologically applicable study of the effects of concomitant changes of several parameters.
Model interaction approach
As stated above, the first step to couple models in M D and M C is to define specific inputeoutput linear or non-linear transformations: D is much higher. In this case, the scaling transformation can be applied in the time domain by means of filtering and subsampling ). Down-scaling methods can be applied when defining T k;n C;D , in particular when one output in O C should be connected to many inputs in I D . A variety of upscaling or down-scaling methods have been proposed in the literature (Auger and Lett, 2003; Lischke et al., 2007) . The complex nature of the physiological systems, however, makes the application of analytic methods difficult, especially when coupling models defined under different mathematical formalisms.
Yet another case is when the physical units of variables in I C;l ðnÞ and O C;l D are different. In this case, T l;n D;C will additionally include the unit conversion process. However, in some cases, these variables may be represented in relative or arbitrary units, requiring the estimation of specific parameters P l;n TCD in order to define an appropriate model interaction. Section 3 presents several examples of the definition of such transformations, when integrating heterogeneous models within the Guyton models. These transformations are implemented in M2SL through specific inputeoutput "coupling objects".
The second step of the coupling method includes the definition of appropriate simulators and simulation parameters for each model in M D and M C . This step is particularly important when the dynamics of these models are significantly different or when the models have been developed under different mathematical formalisms. In order to address this problem, M2SL is based on the co-simulation principle, in which each model is associated with a specific simulator, adapted to the mathematical formalism of the corresponding model. These simulators can be represented as:
where S h U;v is the simulator for model M h U;v , h˛fa; Coupg for atomic or coupled models, respectively, and P S U;v is a vector defining the simulation parameters (including specific model parameter values, initial conditions, integration step-size for continuous models, etc.). Each S a U;v may thus use a different simulation method, with different simulation time-steps. The coupling of all atomic models is performed within the M Coup model that contains them, through an S Coup U;v . Three different strategies for coupling and synchronizing all atomic models are implemented in S Coup U;v objects: i) simulation and synchronization with a unique, fixed time-step; ii) adaptive simulation of atomic models and synchronization at the smallest time-step required by any of the atomic models; and iii) synchronization at a fixed time-step and atomic simulation with independent, adaptive time-steps. More details on these different simulation strategies, with examples on the Guyton model, are presented in Hernández et al. (2009) .
Results
Whole-model sensitivity analysis
Using the Morris method described above, we carried out an extensive sensitivity analysis using the 1992 version of Guyton's model, implemented by us to allow looping over the various model parameters. Here, p ¼ 50, and the size of the perturbations, ∆, was taken to be 5/(p À 1); that is, for each parameter, the range of values between its minimum and its maximum values was split into 50 slices, and the size of the perturbation ∆ corresponded to one-tenth of this range. In our M G92 , we have 296 model variables of interest and 96 input parameters of physiological interest (for which we defined workable minima and maxima based, as far as possible, on physiological criteria from the experimental and clinical literature), and r ¼ 1000.
For a given x j , we start with a randomized input vector b x and evaluate the output variables b y before and after increasing x j by ∆. These results give a value of ee ij for each of the y i output variables at each selected time (see above). In this case, each elementary effect ee ij is normalized by the value x j =y i ð b xÞ. This is repeated r times to produce a random sample of r elementary effects of x j . Then, this process is repeated for each of the Nx input parameters. The total computational cost is 2r times Nx ¼ 192,000 simulations; each of these represents a virtual patient. The frequency distribution of the blood pressure variable (PA) was approximately normal, and simulated PA values ranged from 80 to 189 mmHg, of which 109,266 were "hypertensive" (steady state PA > 106.6 mmHg) and 82,734 were normotensive (steady state PA 106.6 mmHg).
We also carried out a covariance analysis (results not given here) that gives valuable information about the interdependencies of parameter effects on any given variable, thus providing pointers for a more physiologically applicable study of the effects of concomitant changes of several parameters. These results also provide a good starting point for the use of such a core-model for systematic in silico exploration of possible new drug effects, hypotheses about successive perturbations leading to disease states, or alternative treatment strategies. As stated above, an additional outcome is the production of a virtual population, where each virtual individual is characterized by a set of parameter values and the associated outputs (analagous to phenotypes). Specific real-world patients could be associated with one or more of these virtual individuals by doing a sort to match available clinical indicators against the values of identifiable model parameters and variables (e.g., arterial pressure, cardiac output, rate of glomerular filtration, hematocrit, blood viscosity,.).
Since the results of this global analysis are voluminous and lie outside the main focus of the present paper, we give here, in Fig. 3 , just a sample of the results using the virtual populations, namely, an indication of the 10 parameters whose values were at least 5% different in the normotensive and hypertensive subpopulations. Fig. 3 . For parameters whose means differed by at least 5% in the hypertensive subpopulation compared to the normotensive subpopulation, the graph shows mean AE SD of the parameter value in the hypertensive subpopulation normalized by the respective means in the normotensive subpopulation (M NT ), i.e., (mean/M NT ) AE (SD/ M NT ). Of the 192,000 simulated virtual patients generated by randomization of the M G92 input parameters, 109,266 were hypertensive (PA ! 106.6 mmHg). The differences were highly statistically significant. Parameters whose mean value increased by >5% in hypertensives are: AARK (basic afferent arteriolar resistance), ANCSN (sensitivity controller of ANM), CPR (critical plasma protein concentration for protein destruction), KORGN (gain of positive feedback, Korner concept), LPPR (rate of liver protein production). Parameters whose mean value decreased by >5% in hypertensives are: AUTOK (rate of development of very rapid autoregulation), AUV (blood volume shifted from unstressed to stressed), CPF (pulmonary capillary filtration coefficient), EARK (basic efferent arteriolar resistance), GFLC (glomerular filtration coefficient).
Values Parameters
Certain of these parameters come as no surprise; e.g., one expects to see that the afferent and efferent glomerular arteriolar resistances (AARK and EARK, resp.), the glomerular filtration coefficient (GFLC), and the level of salt intake in the diet (NID; see also section 3.3). The others, however, invite deeper reflection and will be analyzed in more depth in subsequent focused studies. Such studies are beyond the scope here; indeed, the results shown in Fig. 3 should not be interpreted too hastily. The reader will realize that although the means of these 10 parameters were significantly increased or decreased in the virtual patients with hypertension, one cannot conclude that any particular combination of them was systematically altered in particular virtual individuals. The sorting out of interesting relationships on this score is the object of ongoing work to be published separately.
Integration of an elastance-based pulsatile heart model
Heart failure (HF) is a multifactorial syndrome that may be caused by a number of genetic and environmental factors. This syndrome is mainly characterized by a reduced cardiac output, due to an alteration of the cardiac mechanical properties during systole and/or diastole and, in some cases, its electrical properties (intra or inter-ventricular desynchronization of the cardiac electrical activation). Regulatory mechanisms are established in the early stages of HF to compensate for the reduced cardiac output. These mechanisms include an elevated sympathetic tone (which increases heart rate, blood flow and blood pressure) and a remodeling of the ventricular tissue. Even if these regulatory mechanisms can compensate for short-term lack of contractility, they become deleterious in the mid-to long-term and may increase the mechanical ventricular dysfunction, causing a permanent increase in pre-load and afterload, pulmonary or peripheral edema, decreased renal output and dyspnea on exertion (McMurray, 2010) .
The Guyton models include simplified representations of a number of regulatory mechanisms that are central to the analysis of HF (Fig. 1) . However, the cardiac module in M G72 and M G92 is a non-pulsatile model providing only mean values of the main hemodynamic variables via a static cardiac function curve. This is an important limitation when studying HF for several reasons: i) the significant modifications of this syndrome on ventricular contractility during systole, diastole, or in the presence of a biventricular desynchronization cannot be represented, ii) some useful clinical variables, such as the maximum value of the arterial pressure derivative (dP/dtmax) or the evolution of the systolic and diastolic pressures, cannot be simulated, and iii) a more realistic representation of short-term regulatory loops (such as the baroreflex) requires these pulsatile variables.
In this sense, the general method proposed in section 2.2 will be applied here to replace the original, non-pulsatile cardiac submodel of M G72 with an elastance-based pulsatile model of the heart, including interventricular interaction through the septum (M G72-P ). In this case, the set M R is the Heart sub-module, located within the Circulatory Dynamics coupled module. O C ¼ {PLA (left atrial pressure), PA (arterial pressure), PRA (right atrial pressure), PPA (pulmonary arterial pressure), AUR (autonomic effect on heart rate) and AUH (autonomic effect on heart strength)} and I C ¼ {QMI (mitral flow), QLO (left ventricular outflow), QTR (triscupid flow), QRO (right ventricular outflow)}. Fig. 4 depicts the integration of the new models within the Circulatory Dynamics coupled module and within M G72 .
Sensitivity analysis of the Circulatory dynamics module
An inputeoutput sensitivity analysis has been applied to the Circulatory Dynamics sub-models of the M G72 and M G92 models in order to optimize the design of the new pulsatile model and define the model integration scheme. The two versions of the Guyton model have somewhat different structures. Although in both models the Circulatory Dynamics module has 15 outputs, it has Nx ¼ 16 inputs in M G72 and Nx ¼ 23 in M G92 . The Morris screening method, as described in (Morris, 1991) , has been applied with p ¼ 20 and D ¼ p/(2(p À 1)) ¼ 0.526. The total number of simulations performed for this analysis was n ¼ 5Nx(k þ 1), where Nx is the total number of inputs, as defined earlier. The simulations were run 1 min to obtain a steady state before effecting an input perturbation. Results are represented by means of mes planes, where m and s are, respectively, the absolute mean value and the standard deviation of the set of elementary effects (ee ij ) computed for each input j of each Circulatory Dynamics module. Fig. 5 (a) and (b) depicts the sensitivity analysis results on the mean arterial pressure obtained respectively from the M G72 and M G92 models. In both cases, the simulated arterial pressure is particularly sensitive to modifications of: i) total blood volume, ii) the autonomic modulation of the cardiac activity and iii) vessels contractile state. The Circulatory Dynamics output plasma volume (VP, both in M G72 and M G92 ) is one of the most significant factors, since the liquid component of blood directly affects the total blood volume. Furthermore, the vascular volume caused by relaxation (VVR), also has an important influence on the arterial pressure, since it directly reflects constriction of venous vessels, driven by autonomic activity. Variables representing the autonomic nervous system (ANS) modulation (AU for M G92 and AUH and AUM on both M G72 and M G92 ) have a significant influence on the simulated arterial pressure, since it regulates cardiac contractility, heart rate and peripheral vasoconstriction. Particular attention will be paid to the integration of these variables into the new pulsatile model. The main differences between the two versions of the model concern the influence of hypertrophy effects on the ventricle (HPL and HPR), which is more important in the M G72 model. These variables will not be coupled to the pulsatile cardiac model, since new state variables will allow for the modification of different aspects of cardiac contractility in a more detailed fashion.
Integration of the new cardiac sub-module
In this section, we first describe the proposed cardiac pulsatile model (M D ) and then the coupling approach between this model and those in M C . The set M D is constituted here of one coupled model, including atomic models which represent the four cardiac valves, two pulsatile ventricles, and the interventricular septum (see Fig. 4 ). Cardiac valves are represented by modulated resistances. Atomic models representing both ventricles are described by elastic chambers (Smith et al., 2004) . One cycle of ventricular elastance is given by:
where A ¼ 1, B ¼ 250 s À2 and C ¼ 0.27 s are parameters that define the function's profile, and variable t e corresponds to the time elapsed since the last ventricular electrical activation. Ventricular pressureevolume loops are characterized by the End Systolic PressureeVolume Relationship (ESPVR) and the End Diastolic PressureeVolume Relationship (EDPVR), which can be defined as P es ðVÞ ¼ E es ðV À V 0 Þ and P ed ðVÞ ¼ P 0 ðe lðVÀV 0 Þ À 1Þ. The end systolic pressure (P es ) is described as a linear relationship between the volume (V), the volume at zero pressure (V 0 ) and the end systolic elastance (E es ), while end diastolic pressure (P ed ) is defined by a non-linear relationship defined by the elastance of ventricular walls during diastole (P 0 ) and the curvature of the EDPVR (l). The ventricular pressure-volume relationship can be defined as:
PðVÞ ¼ eðtÞP es ðVÞ þ ð1 À eðtÞÞP ed ðVÞ:
The Smith model describes the interaction between the two ventricles through the interventricular septum by defining the left and right ventricular free wall volumes, as follows (Smith et al., 2004) :
a b Fig. 5 . Inputeoutput sensitivity analysis for the mean arterial pressure (PA) on the Circulatory Dynamics module of M G72 (a) and M G92 (b). The inputs analyzed are: VP (plasma volume), VRC (volume of red blood cells), AUH (autonomic effect on heart strength, ratio to normal), ANM (general angiotensin multiplier effect, ratio to normal), VVR (basic venous volume), VV6 (vascular volume caused by long-term stress relaxation), VV7 (vascular volume caused by short-term stress relaxation), PC (capillary pressure), AUM (sympathetic vasoconstrictor effect on arteries), AUY (sensitivity of sympathetic control of veins), VIM (blood viscosity effect on resistance), ARM (non-muscle global autoregulation multiplier), AMM (overall multiplier factor for muscle autoregulation), RBF (renal blood flow), HMD (cardiac depressant effect of hypoxia), HPL (hypertrophy effect on left ventricle), HPR(hypertrophy effect on right ventricle), ADHMV (effect of ADH on nonrenal vascular résistance), ANU (angiotensin effect on arterial resist þ venous volume), ANUVN (effect of angiotensin on systemic veins), ATRRFB (volume receptor feedback on arterial résistance), ATRVFB (volume receptor feedback on unstressed venous volume), AU (overall activity of autonomic system), AVE (autonomic effect on venous résistance), OSA (aortic oxygen saturation).
where Vspt represents the volume modification due to septal dynamics. Pressures for the ventricles and the septum are described by applying equation (6) 
The relation between the septum, the left, and the right ventricles is defined by Pspt ¼ Plvf À Prvf.
To summarize, the inputs of the pulsatile model are I D ¼ {t e , PA (arterial pressure), PLA (left atrial pressure), PRA (right atrial pressure) and PPA (pulmonary arterial pressure)} and its outputs O D ¼ {QMI (flow through the mitral valve), QLO (flow through the aortic valve), QTR (flow through the tricuspid valve), QRO (flow through the pulmonary valve)}. In order to couple this model with elements in M C , these I D and O D should be connected to the corresponding elements in O C and I C , defined previously, through coupling objects integrating appropriate transformations T D,C and T C,D .
The coupling of hemodynamic variables (pressures and flows) is relatively simple in this case, since they are represented with the same physical units in I D , O D , O C and I C . However, the temporal resolution of these variables in I D and O D is significantly different. A first approach, based on the application of a filter for the transformation of these variables has been presented in a previous work . The objective here is to preserve this higher temporal resolution within models in M C , while assuring the stability of the whole coupled model. This point requires the appropriate transformation and coupling of the autonomic regulation variables within the cardiac model and the Systemic Circulation module. Three coupling variables are defined in M G72 for autonomic regulation of the cardiac activity: AUR, AUH and AUM, concerning respectively the regulation of: i) heart rate (chronotropic effect), ii) cardiac contractility (inotropic effect) and iii) systemic resistance. These variables are defined in arbitrary units. Transformations T C,D were thus defined for these variables with the following general equation:
where X stands for AUR, AUH and AUM and S X and B X are, respectively, sensitivity and baseline controllers that can be tuned to adjust the level of autonomic regulation. The resulting transformed variables AUR T , AUH T and AUM T should be further processed and coupled to the pulsatile model before performing the estimation of appropriate parameter values for S X and B X . In order to integrate the chronotropic effect, an Integral Pulse Frequency Modulation (IPFM) model (Rompelman et al., 1977) was included within a transformation linking variable AUR T (used as input to the IPFM model) and variable t e of equation (5). The IPFM model generates a pulse corresponding to the electrical activation instant used for all elastances (e lvf , e rvf and e sept ). Concerning the integration of the inotropic effect, variable AUH T was used to modulate the ventricular elastance as follows:
where E es0 is the basal value for the end-systolic elastance, which is an internal parameter of M D . Furthermore, in order to assure the stability of the new global, coupled model, the original AUM variable, controlling the systemic resistance in the Systemic Circulation sub-model, was replaced by the transformed AUM T variable.
Finally, appropriate values for parameters P TCD ¼ [SAUR, SAUH, SAUM, BAUR, BAUH, SAUM] were estimated by applying an optimization algorithm configured to minimize an error function defined between the simulations obtained from M G72 and those obtained from M G72-P . A known benchmark simulation of the Guyton models was used during the parameter optimization process, which consists of doubling the resistance of non-renal circulation, such as the one that can be caused by the injection of vasoconstrictor drugs, at t ¼ 1 min (Van Vliet and Montani, 2005 ). An evolutionary algorithm was used to minimize an error function 3, defined as:
ðjPA G72ÀP ðtÞ À PA G72 ðtÞj þ jAU G72ÀP ðtÞ À AU G72 ðtÞj þ jQLO G72ÀP ðtÞ À QLO G72 ðtÞj þ jRs G72ÀP ðtÞ À Rs G72 ðtÞjÞ: (12) where variables PA G72 , AU G72 , Rs G72 and QLO G72 correspond to the original Guyton output variables and PA G72-P , AU G72-P , Rs G72-P and QLO G72-P stand for the output of the Guyton model including pulsatile ventricles. PA, AU, Rs and QLO are respectively the mean arterial pressure, the autonomic activity (which is not an input of the Circulatory Dynamics module on M G72 ), the resistance in nonrenal circulation and the cardiac output.
Simulation results and discussion
Fig . 6 shows the comparison between the simulations obtained with M G72 and M G72-P for a sudden increase of global peripheral resistance (simulation experience used during the parameter identification stage). In order to compare simulation results from both models, each pulsatile variable obtained from M G72-P was post-processed to obtain beat-to-beat mean, systolic and diastolic values, with the following procedure: i) detection of each beat, ii) estimation of the minimum and maximum (diastolic and systolic) values for each beat and iii) estimation of the mean value by integrating each variable on the time support associated with each beat and dividing by the cardiac period. These beat-to-beat variables are superposed to the original M G72 variables in Fig. 6 . A close match between the results obtained from M G72 and the post-processed M G72-P variables can be observed. In both cases, the rise of the systemic resistance provokes a transient increase of arterial pressure level that rapidly leads to a decreased activity of the renineangiotensin and the sympathetic systems. As a consequence, arterial pressure level is stabilized at a slightly higher value, and cardiac output falls to a lower level. In addition, the evolution of the systolic and diastolic values of the arterial pressure (segmented lines on Fig. 6a ) can be analyzed from M G72-P . An example of the pulsatile hemodynamic variables generated by M G72-P is shown in Fig. 7 . These variables present values that are consistent with known physiological data.
The reproduction of the in silico experiments described in (Guyton et al., 1972) , which has already been studied for our implementation of M G72 in (Thomas et al., 2008) , has also been performed with M G72-P . As an example, results obtained from benchmark experiment 1 in (Thomas et al., 2008) provided a mean relative root mean squared error (rRMSE) equal to 0.0203 when comparing the set of output variables of M G72 with M G72-P , which is an acceptable result. rRMSE for the most sensitive variables are the following: extracellular fluid volume (VEC), rRMSE ¼ 0.011; blood volume (VB), rRMSE ¼ 0.012; sympathetic stimulation (AU), rRMSE ¼ 0.01; heart rate (HR), rRMSE ¼ 0.012 and arterial pressure (PA), rRMSE ¼ 0.01.
Finally, the impact of the integration of the pulsatile model within the original Circulatory Dynamics sub-model was analyzed through a new sensitivity analysis. Fig. 8 shows the Morris inputeoutput sensitivity results on arterial pressure. Compared to the sensitivity analysis performed on the Circulatory Dynamics submodel of the original M G72 model (Fig. 5a) , the most sensitive variables are still the plasma volume (VP), the autonomic regulation of vasoconstriction on arteries (AUM), and the vascular volume caused by relaxation (VVR). It is possible to observe an increased sensitivity to inputs that modulate the systemic resistance: ANM (general angiotensin multiplier effect, ratio to normal), ARM (nonmuscle global autoregulation multiplier), and AMM (overall multiplier factor for muscle autoregulation). This difference can be explained by the fact that the new cardiac model integrates a more realistic response to variations in preload and afterload.
The modifications performed in this section are an important initial step toward the adaptation of the Guyton models for a systemic analysis of heart failure. In previous work, we have proposed hybrid, tissue-level electromechanical models of cardiac function and parameter identification methods that are able to reproduce regional echocardiographic strain data from patients suffering from HF (Fleureau et al., 2009; Le Rolle et al., 2008) . However, the hemodynamic boundary conditions of these models were not realistic and none of the short or long-term regulatory mechanisms of the cardiovascular system were integrated. Current work is thus directed to couple these models with the Guyton models, by applying the method proposed in this paper in order to study new diagnostic and therapeutic approaches to heart failure. Indeed, preliminary results integrating a model of a cardiac resynchronization pacemaker with a hybrid elastance-based cardiac model, coupled with systemic and pulmonary circulations, have shown the importance of the joint analysis of these systems for the correct definition of patient-specific stimulation parameters (Tse Ve Koon et al., 2010) . Section 3.3 below is devoted to the improvement of another important subsystem of the Guyton models for the analysis of this pathology (as well as hypertension), namely the renin-angiotensin system.
Integration of a model of the endocrine renineangiotensin system
In normal CVR physiology, homeostasis of body sodium and arterial pressure (PA) strongly relies on the renineangiotensin system (RAS). In CVR disease, the paramount role of RAS is substantiated by a systematic involvement in hypertension, heart and kidney failure, atherosclerosis, diabetes and metabolic syndrome (Hsueh and Wyne, 2011) . As a consequence, RAS is a primary target for pharmacological agents (ACE, angiotensin-converting enzyme, inhibitors, angiotensin receptor blockers, direct renin inhibitors)d and dietary maneuvers such as sodium restrictionddirected against such pathologies (Atlas, 2007) . For instance, RAS activation associates with higher risk of cardiovascular events, whereas drug action (e.g. ACE inhibition), as well as sodium restriction, reduces cardiovascular mortality and slows kidney disease progression (Brown, 2007) .
RAS is an endocrine cascade that starts with renin (REN) production by the renal juxtaglomerular apparatus (JGA), in response to a decrease in PA, natremia and/or volemia. REN is an enzyme which converts circulating angiotensinogen (AGT, a liver-derived glycoprotein) into angiotensin I (Ang I). This inactive peptide is then converted by ACE to angiotensin II (Ang II). Ang II is the major RAS effector, adjusting PA, salt (and water) via i) arterial and venous vasoconstriction, ii) renal sodium reabsorption, iii) thirst and salt appetite, and iv) secretion of aldosterone (for a review, see Atlas, 2007 ; for tissue-specific aspects, see Paul et al., 2006) .
In the original M G72 model (and M G92 ), the treatment of RAS is restricted to the ANM signal (angiotensin multiplier effect on vascular resistance, ratio to normal), modulating peripheral resistance and aldosterone production (Guyton et al., 1972) . Encompassing both REN and Ang II, ANM is an 'average' measure of RAS activation, produced by a dedicated module (Angiotensin control) under the inhibitory influence of the 'macula densa', MD (via GF3 signal in M G72 ), a key element in the feedback control of glomerular filtration rate. As a consequence, the original Guyton models contain no specific inclusion of those RAS regulators and elements that are widely targeted by pharmacology and clinics (Atlas, 2007; Brown, 2007) , i.e.: i) RAS biochemical actors (AGT, REN, Ang I, ACE, Ang II), and ii) established physiological regulators of renin production (other than MD), namely PA, Ang II, and renal sympathetic nerve activity (RSNA). Thus, the improvement of RAS description constitutes a sine qua non step toward the rational exploitation of such models in human pathology, pharmacology or clinics.
Contrary to cardiac or autonomic CVR regulation, there are few dedicated models of endocrine systems, especially for the RAS. To our knowledge, two 'stand-alone' RAS models have been proposed. Focusing upon primary aldosterone-induced hypertension, Hsieh and coll. developed a RAS model to predict renin and aldosterone changes under short-term diuretic treatment (Hsieh et al., 1990 ). Takahashi and coll. developed a steady-state RAS model of reactions leading to Ang II formation, combined with gene expression of RAS-elements (AGT, REN, ACE) (Takahashi et al., 2003) . In addition, as in the Guyton models (Guyton et al., 1972; Montani and Van Vliet, 2009 ), RAS descriptions have been proposed as modules integrated within CVR circulatory models (Ikeda et al., 1979; Karaaslan et al., 2005; Uttamsingh et al., 1985) . However, all these models lack several of the following features of RAS: realistic system dynamics, explicit enzymes and kinetics, representation of the main renin regulators (PA, Ang II, MD, and RSNA), validation against human clinical data.
In order to fill these gaps, we recently developed a realistic model of RAS for integration into M G72 (Guillaud and Hannaert, 2010) . In brief, our model integrates the following missing elements, i.e., i) biochemical elements (from AGT to Ang II) in a Plasma model, ii) physiological renin regulators, in a JGA model. After parameter optimization, the whole construct was validated against human data (Guillaud and Hannaert, 2010) .
Here, we present the modular organization of the new M G72-RAS module, the sensitivity analysis of the original and new models (in terms of RAS and kidney function), and simulation experiments demonstrating the benefits of the new RAS in terms of physiological behavior of the integrated CVR model. glomerular filtration (GFN) was primarily modulated by SNAdependent arteriolar tone (AUM), PPC (plasma colloids), and PA; these 3 variables exhibited interdependent influences upon GFN (s > 0); other inputs had negligible effects on GFN (i.e.
close to [0, 0] in the mes plane); NAE and NOD were equally and interdependently influenced by AM, AUM, PA, PPC, NID, and STH, while VUD depended on PA, PPC, and REK; much like GFN, RBF was essentially modulated by AUM and PPC, interactively.
For the RAS model (M c R , AngioC ), we observed that ANM was strongly modulated by GFN and REK, and to a lesser extent by CNA.
Sensitivity analysis of M G72-RAS : Focusing on the 'activation state' of the new RAS, I/O sensitivity analysis showed that the introduction of PA as a regulator led to its quantitative preponderance upon ANM output (the other inputs collapsed around 0,0 in the m,s plane). On the other hand, CNA (while conserving its expected sole influence, see above) lost some 'quantitative' influence upon CNE, possibly due to a 'dilution effect'.
Simulation results and discussion
As mentioned, one essential function of RAS is to contribute to PA, natremia, and body fluids homeostasis. In this process, renin catalyzes the first step in the RAS cascade, in fine leading to sodium retention and adjustment of PA and volemia. In this physiological context relating RAS to sodium intake and PA regulation, we performed simple in silico experiments in order to evaluate the putative gains brought about by the presence of new RAS in Guyton's circulatory model.
The steady-state dependence of plasma renin activity (RA), a measure of the RAS activation, on natriuresis (RA ¼ f(NOD), i.e. the so-called 'Laragh's nomogram'), is a well-established observation (Laragh, 2001) . Thus, we compared RAS activity of M G72 and M G72-RAS models as a function of NID (or NOD, at steady-state): the ANM factor was used for comparison because it is the sole RAS variable common to both models. Fig. 10 plots ANM factor versus NID. In the clinical setting, the referred biological variable is plasma RA: in order to position model outputs vs. 'real' plasma RA values, we also plotted lower and upper limits for normotensive patients, as ANMequivalents, recalculated from Laragh (2001) (see legend of Fig. 10) . Globally, it can be seen that both models produce the known and expected inverse, curvilinear relationship between sodium input and RAS activation (Laragh, 2001 (Laragh, , 1995 . However, the new model performs better than the native one, for two interdependent reasons. First, M G72-RAS outputs are well confined within the operational definition of normal values (dotted lines on Fig. 10 ), whereas M G72 ANM outputs fall outside the physiological range, beyond 150 mEq/d. Second, the new construct appears about 50 % more 'responsive' to sodium input than the original, since ANM varies in a 0.45 range (0.80e1.25), instead of 0.30 (0.97e1.27) for M G72 . In particular, whereas ANM/M G72 was practically unable to respond to NID increases beyond 150e200 mEq/d, as opposed to observed clinical behavior (see Fig. 10 , upper and lower limits, as dotted lines), the new ANM signal proved able to do so: in the 150e300 mEq/d NID, the average ANM slope of the new model is 3-fold higher than the original one (0.11 vs 0.04 (100 mEq/d) À1 ). In the present epidemiological context of excess sodium intake, this is of importance (Smith-Spangler et al., 2010) . The introduction of the new RAS module rendered the CVR circulatory-blood pressure homeostasis model more responsive, and over a wider range of sodium intake (10e300 mEq/d) known to be influential and patho-physiologically relevant (Laragh, 2001) . In large part, this is due to the introduction (in addition to MD signal) of three key physiological REN controllers: the inhibitory PA and Ang II, on the one hand, and the stimulatory RSNA on the other hand. Indeed, an exploratory numerical analysis of the individual contributions of the four signals to NID-induced 'renin modulation' showed that Ang II (inhibitor) and RSNA (activator) dominate the response in the 30e300 mEq/d NID (data not shown). This further illustrates the gain brought about by the new RAS. One known system-level characteristic of the RAS is its baseline state of tonic inhibition, according to a dynamic balance between inhibitory (PA, MD, Ang II) and stimulatory (RSNA) influences. Obviously, this could not be accomplished by M G72 since in that model only MD (GF3 signal) controls RAS (ANM factor).
This observation points out the relevance and potential of the advocated 'progressive systems physiology' approach in the CVR context of and hypertensive patho-physiology since: (i) it is known that one major action of b-blockers to reduce blood pressure involves the inhibition of RSNA, thus reducing renin release (Brown, 2007) , and (ii) more generally, the relative contributions of renin controllers (e.g., PA vs MD signals, vs Ang II, etc) remain a subject of investigation, not only because these contributions are intrinsically complex (e.g., the PA variable acts both via renalarteriolar baroreceptor and via RSNA), but also because they depend on individuals and on their patho-physiological/clinical context.
In conclusion, the modular expansion of M G72 into M G72-RAS carried out brings in return a more realistic model of the dynamic and coupled interactions that physiologically occur in the CVR system as it responds to sodium intake via the RAS. Because RAS and sodium are so tightly involved in hypertensive and CVR diseases, this opens the avenue toward pathophysiology, pharmacology and therapeutics, including variabilities and genetic polymorphisms (Jiang et al., 2009; Laragh, 2001 Laragh, , 1995 Rudnicki and Mayer, 2009; Takahashi et al., 2003) .
Conclusions and perspectives
With the emergence of integrative physiology and international projects such as the IUPS Physiome and the European Virtual Physiological Human (VPH), an increasing interest exists today toward the integration of different physiological models, which may cover different functions and be developed at various scales, under distinct mathematical formalisms. This paper presents a contribution to the formalization of the seldom-covered problem of the appropriate definition of the interfaces required to perform this model integration. It also proposes an approach to interface such heterogeneous models, by i) restructuring and modularizing the different models to be coupled, ii) analyzing their inputeoutput sensitivity, and iii) defining appropriate inputeoutput transformations and simulation methods.
The proposed approach has been applied to the extension and updating of the somewhat outdated but well-validated classic Guyton model in two ways: i) by replacement of one of its central modules with a more detailed and up-to-date module, and ii) by insertion of a major new module whose details have been discovered over the decades since development of the classic model.
In the first instance, the original Circulatory dynamics module was replaced in order to transform the overall model so it could represent pulsatile blood pressure, whereas the original model represents only mean arterial pressure. This required installation of an adequate dynamic representation of the left ventricle, wholly missing from the original model. In the second instance, a recent and original detailed model of the RAS system was inserted into the global model. The effect of these modifications on local and overall model behavior is assessed using an extensive sensitivity analysis.
Both of these extensions bring significant new functionality to the model, enabling in silico exploration of physiological processes inaccessible to the original model. Both extensions also required a number of non-trivial adjustments to the other parts of the global model. The process of extension was made possible thanks to the powerful multi-resolution reformulation of the original Fortran model into Cþþ for solution using the M2SL package.
However, beyond the added functionality of the extended model, which still has to be validated, the central focus here is on the open, re-usability of the core-model approach, in the physiome spirit. Ours is not the first reformulation of the Guyton modelsdit has also been re-implemented in Matlab/Simulink (Kofranek and Rusz, 2010; Kofranek et al., 2007) and more recently in Modelica (Kofranek, personal communication). It is also not the most advanced extension of the Guyton modelsdsee for example the elaborate QCP/QHP/HumMod environment developed over the years by Guyton's collaborators (Hester et al., 2011) . Nonetheless, given the unwieldy underlying description of the HumMod model (over 5000 variables, described in several thousand XML files) and the slow execution time and proprietary context of the Matlab/Simulink implementations, the project presented here is better geared to the goal of providing an open, collaborative context for continued extension and building up of integrated models of human physiology. To this end, the computer code for the models described here will be made available through the Virtual Physiological Human Network of Excellence ToolKit. Moreover, the proposed multiresolution approach differs from a purely Top-Down, Bottom-Up or Middle-out approach, as discussed in (Hester et al., 2011) , since it and M G72-RAS . NID was sequentially varied and model was allowed to reach (quasi) steady-state (5 days: sodium excretion NOD > 0.9 NID). Upper and lower limits of normotensive subjects are shown (Laragh, 2001 ); these 'ANM-equivalent' values were obtained by linear mapping of the clinical interval (0e6 Â 10 À11 mol/(l min) to the operational model interval for ANM (0.65e1.35; see Guillaud and Hannaert, 2010) . Abbreviations: ANM, general angiotensin multiplier effect; NID, rate of sodium intake; NOD, rate of sodium output (natriuresis).
allows to selectively up-scale or down-scale different components of the core-model as a function of the targeted application.
Some future extensions along the same lines have already been cited in the paper. Other possible extensions, which could be carried out by ourselves or others, could be: merger into the coremodel of models to treat acid-base regulation in significantly more detail; replacement of the Kidney module to provide more explicit representation of known targets (i.e., ion channels, membrane transporters, hormone receptors, etc.) of drug therapy for hypertension and other kidney-related diseases; or better representation of the role of renal sympathetic nerve activity (Karaaslan et al., 2005) , to name only three.
As the VPH/Physiome projects develop, an overarching goal is to work toward not only horizontal integration across organ systems, but also vertical integration across different levels of organization, from whole body down to cellular processes, metabolism, and relevant gene-regulatory processes to get at the genotype-tophenotype relationships (Houle et al., 2010; Hunter et al., 2010; Martens et al., 2009 ). The work described here is intended as a step in this direction.
b y ¼ f b x ; b yh y 1 ; .; y Ny ; b xhðx 1 ; .; x Nx Þ;
we wish to estimate both the sensitivity of each y i to each x j ,
and the degree to which the effect of x j depends on the values of x k , k s j. To this end, we adopted the method of Morris (1991) , which estimates not only the mean effect of each input or parameter on each model variable, but also the dependence of each parameter effect on variations of the other model parameters. A normalized measure of parameter sensitivity, the elementary effects, or ee ij , is thus defined as the fractional change of variable y i after a small perturbation of parameter x j , scaled by the corresponding parameter changes. These elementary effects are thus defined as: 
where ∆ is the applied perturbation. Attention was restricted to a region of the parameter (or input variable) space u, a regular Nx-dimensional p-level grid, where each x j takes values from {0, 1/(p À 1), 2/(p À 1), ., (1 À ∆)}. Values for p and ∆, are defined for every analysis. We designate as F ij the distribution of ee ij in a number r of computational experiments, done with r randomized vectors b x (with each x j drawn at random within the predefined grid). The resulting estimates of the absolute value of the mean m i,j and the standard variation s i,j of the ee ij , are indicators of which input parameters are important: a large value of m i,j indicates that the parameter x j has a significant overall effect on the output, while a large value of s i,j is associated with non-linear effects or with strong interactions with other parameters. Results from this sensitivity analysis can be represented graphically on the mes plane.
